DTP Distribution Model Under Threat

AstraZeneca's direct-to-pharmacy (DTP) distribution system limits equal access to the drugmaker's products, Poland's Main Pharmaceutical Inspectorate (GIF) has said. The GIF said that the scheme contravenes provisions of the Pharmaceutical Law and the Law on Health Benefits, which requires wholesalers and manufacturers to ensure delivery on equal terms to all entities in the distribution chain. AstraZeneca has the right to appeal and has responsed to the GIF with its arguments for the

To read the full article, please choose one of the following options: